Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments

benzinga.com/markets/biotech/25/09/47671623/monte-rosa-novartis-use-ai-powered-engine-to-advance-immune-disease-treatments

Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) stock is surging on Monday, with a session volume of 11.67 million compared to the average volume of 408.08 thousand as per data from Benzinga Pro.
Monte Rosa announced a collaboration with Novartis AG (NYSE:NVS) to develop novel degraders for…

This story appeared on benzinga.com, 2025-09-15 15:29:40.
The Entire Business World on a Single Page. Free to Use →